Mecamylamine does not precipitate withdrawal in cigarette smokers

Psychopharmacology

Volumn 127, Issue 4, 1996, Pages 328-336

  Eissenberg, Thomas ^a   Griffiths, Roland R ^a   Stitzer, Maxine L ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Antagonist precipitated withdrawal; Antagonists; Mecamylamine; Nicotine; Physical dependence; Withdrawal

Indexed keywords

ANTIHYPERTENSIVE AGENT; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR BLOCKING AGENT; PLACEBO;

ADDICTION; ADULT; ARTICLE; BLOOD PRESSURE; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE; HEART RATE; HUMAN; MOOD; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TASK PERFORMANCE; WITHDRAWAL SYNDROME;

ADULT; BLOOD PRESSURE; CARBON MONOXIDE; FEMALE; HEART RATE; HUMANS; MALE; MECAMYLAMINE; MIDDLE AGED; NICOTINIC ANTAGONISTS; SMOKING; SMOKING CESSATION; STIMULATION, CHEMICAL; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0029972206     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050094     Document Type: Article

References (30)

1. Clarke PBS, Kumar R (1983a) The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br J Pharmacol 78:329-337
2. Clarke PBS, Kumar R (1983b) Nicotine does not improve discrimination of brain stimulation reward by rats. Psychopharmacology 79:271-277
3. Eissenberg T, Greenwald MK, Johnson RE, Liebson IA, Bigelow GE, Stitzer ML (1996) Buprenorphine's physical dependence potential:antagonist-precipitated withdrawal in humans. J Pharmacol Exp Ther 276:449-459
4. Fagerstrom KO (1978) Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 3:235-241
5. Griffiths RR, Bigelow GE, Liebson, I (1983) Differential effects of diazepam and pentobarbitol on mood and behavior. Arch Gen Psychiatry 40:865-873
6. Hall GH (1972) Changes in body temperature produced by cholinomimetic substances injected into the cerebral ventricles of unanesthetized cats. Br J Pharmacol 44:634-641
7. Himmelsbach CK (1941) The morphine abstinence syndrome, its nature and treatment. Annu Int Med 15:829-839
8. Hughes JR (1994) Non-nicotine pharmacotherapies for smoking cessation. J Drug Dev 6:197-203
9. Hughes JR, Hatsukami DK (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43:289-294
10. Hughes JR, Hatsukami DK, Pickens RW, Krahn D, Malin S, Luknic A (1984) Effect of nicotine on the tobacco withdrawal syndrome. Psychopharmacology 83:82-87
11. Malin DH, Lake JR, Carter VA, Cunningham JS, Hebert KM, Conrad, DL, Wilson OB (1994) The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat. Psychopharmacology 115:180-184
12. Martin BR, Onaivi ES, Martin TJ (1989) What is the nature of mecamylamine's antagonism of the central effects of nicotine? Biochem Pharmacol 38:3391-3397
13. McLeod D, Griffiths RR, Bigelow GE, Yingling J (1982) An automated version of the digit symbol substitution test (DSST). Behav Res Methods Instrum 14:463-466
14. McNair DM, Lorr M, Droppelman LF (1971) Profile of mood states (manual). Education and Industrial Testing Services, San Diego
15. Nemeth-Coslett R, Henningfield JE, O'Keefe MK, Griffiths RR (1986) Effects of mecamylamine on human cigarette smoking and subjective ratings. Psychopharmacology 88:420-425
16. Newhouse PA, Potter A, Corwin J, Lenox R (1992) Acute nicotine blockade produces cognitive impairment in normal humans. Psychopharmacology 108:480-484
17. Petrie RXA, Deary IJ (1989) Smoking and human information processing. Psychopharmacology 99:393-396
18. Pomerleau CS, Pomerleau OF, Majehrzak MJ (1987) Mecamylamine pretreatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level. Psychopharmacology 91:391-393
19. Rose JE, Sampson A, Levin ED, Henningfield JE (1989) Mecamylamine increases nicotine preference and attenuates nicotine discrimination. Pharmacol Biochem Behav 32:933-938
20. Rose JE, Behm FM, Westman EC, Levin ED, Stein RM, Lane JD, Ripka GV (1994a) Combined effects of nicotine and mecamylamine in attenuating smoking satisfaction. Exp Clin Psychopharm 2:328-344
21. Rose JE, Behm FM, Westman EC, Levin ED, Stein RM, Ripka GV (1994b) Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clin Pharmacol Ther 56:86-99
22. Schuh KJ, Stitzer ML (1995) Desire to smoke during spaced smoking intervals. Psychopharmacology 120:289-295
23. Shiffman SM, Jarvik ME (1976) Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology 50:35-39
24. Snyder FR, Davis FC, Henningfield JE (1989) The tobacco withdrawal syndrome: performance decrements assessed on a computerized test battery. Drug Alcohol Depend 23:259-266
25. Stitzer M, Morrison J, Domino EF (1970) Effects of nicotine on fixed interval behavior and modification by cholinergic antagonists. J Pharmacol Exp Ther 171:165-177
26. Stolerman IP (1986) Could nicotine antagonists be used in smoking cessation? Br J Addict 81:47-53
27. Stolerman IP, Goldfarb T, Fink R, Jarvik ME (1973) Influencing cigarette smoking with nicotine antagonists. Psychopharmacologia 28:247-259
28. Tennant FS Jr, Tarver AL, Rawson RA (1984) Clinical evaluation of mecamylamine for withdrawal from nicotine dependence. NIDA Res Monogr 49:239-246
29. Tiffany ST, Drobes DJ (1991) The development and initial validation of a questionnaire on smoking urges. Br J Addict 86: 1467-1476
30. Wu KM, Martin WR (1983) An analysis of nicotinic and opioid processes in the medulla oblongata and nucleus ambiguus of the dog. J Pharmacol Exp Ther 227:302-306